PARTNERSHIPS & COLLABORATIONS
Rambam Medtech, Israel
​
Pharmachal and tier-1 Israeli trauma hospital Rambam Health Care Campus are co-developing a new product that combines Pharmachal’s NOPAYNE mini-emulsion drug delivery technology, lidocaine, and a novel peptide drug developed at Rambam that has shown significant potential to speed up wound healing, coagulate bleeding, and encourage the formation of new blood vessels.
​
Magenta Investments, United Arab Emirates
​
Pharmachal is working with leading healthcare company Magenta Investments to distribute several products in the United Arab Emirates and GCC countries.
​
Fiona Stanley Hospital, State Burns Service, Perth, Western Australia
​
Renowned burns specialist Professor Fiona Woods AO has supported the development of NOPAYNE as principal investigator and as a technical advisor to the company.
​
https://www.fionastanley.health.wa.gov.au/Our-services/Service-Directory/Burns
Roosevelt Hospital, Paediatric Burns Unit, Guatemala City
​
Pharmachal has supplied burns products such as NOPAYNE to the Paediatric Burns Unit, led by Dr Lourdes Santiso.
​
Academic Institutions
